Causes and predictors of hospital readmissions in patients older than 65 years hospitalized for heart failure with preserved left ventricular ejection fraction in western Romania

References

• Lloyd-JonesDAdamsRJBrownTMHeart disease and stroke statistics – 2010 update: a report from the American Heart Association Statistics Committee and Stroke Statistics SubcommitteeCirculation2010121e1e17020048228
   PubMed Web of Science ®Google Scholar
• FormigaFChiviteDSoleAFunctional outcomes of elderly patients after the first hospital admission for decompensated heart failure. A prospective studyArch Gerontol Geriatr20064317518516356561
   PubMed Web of Science ®Google Scholar
• BorlaugBARedfieldMMDiastolic and systolic heart failure are distinct phenotypes within the heart failure spectrumCirculation20111232006201321555723
   PubMed Web of Science ®Google Scholar
• PaulusWJTschöpeCA novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammationJ Am Coll Cardiol20136226327123684677
   PubMed Web of Science ®Google Scholar
• JugduttBIAging and remodeling during healing of the wounded heart: current therapies and novel drug targetsCurr Drug Targets2008932534418393826
   PubMed Web of Science ®Google Scholar
• PaulusWJTschopeCSandersonJHow to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart failure and Echocardiography Associations of the European Society of CardiologyEur Heart J2007282539255017428822
   PubMed Web of Science ®Google Scholar
• National Kidney FoundationK/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratificationAm J Kidney Dis2002392suppl 11266
   Google Scholar
• McMurrayJAdamopoulosSAnkerSDESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012Eur Heart J2012331787184722611136
   PubMed Web of Science ®Google Scholar
• MontalescotGSechternUAchenbachS2013 ESC guidelines on the management of stable coronary artery diseaseEur Heart J2013342949300323996286
   PubMed Web of Science ®Google Scholar
• ManciaGFagardRNarkiewiczK2013 ESH/ESC Guidelines for the management of arterial hypertensionEur Heart J2013342159221923771844
   PubMed Web of Science ®Google Scholar
• VahnianAAlfieriOAndreottiFGuidelines on the management of valvular heart disease (version 2012)Eur Heart J2012332451249622922415
   PubMed Web of Science ®Google Scholar
• TenderaMAboyansVBartelinkAMESC Guidelines on the diagnosis and treatment of peripheral artery diseasesEur Heart J2011322851290621873417
   PubMed Web of Science ®Google Scholar
• AlbertiKGZimmetPShawJMetabolic syndrome-a new worldwide definition. A consensus statement from the international diabetes federationDiabet Med20062346948016681555
   PubMed Web of Science ®Google Scholar
• Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia Available from: https://www.idf.org/webdata/docs/WHO_IDF_definition_diagnosis_of_diabetes.pdfAccessed Dec 10, 2012
   Google Scholar
• BlancBFinchCAHallbergLNutritional anaemias. Report of a WHO Scientific GroupWHO Tech Rep Ser1968405140
   Google Scholar
• DecramerMVestboJBourbeauJGlobal Strategy for Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease (GOLD)2013 Available from: www.goldcopd.orgAccessed Feb 20, 2013
   Google Scholar
• LangRMBierigMDevereuxRBChamber Quantification Writing GroupAmerican Society of Echocardiography’s Guidelines and Standards CommitteeEuropean Association of Echocardiography, Recommendation for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of CardiologyJ Am Soc Echocardiogr2005181440146316376782
   PubMed Web of Science ®Google Scholar
• RaoAAsadi-LariMWalshJWilcoxRGrayDQuality of life in patients with signs and symptoms of heart failure – does systolic function matter?J Card Fail20061267768717174227
   PubMed Web of Science ®Google Scholar
• FahrenbergJMyrtekMSchumacherJBrählerEFragebogen zur Lebenszufriedenheit (FLZ) [Questionnaire regarding life quality (Pocket Guide)]. HandanweisungGöttingenHogrefe2000
   Google Scholar
• DemersCMcKelvieRSNegassaAYusutSReliability, validity, and responsiveness of the six-minute walk test in patients with heart failureAm Heart J200114269870311579362
   PubMed Web of Science ®Google Scholar
• SchwartzJBZipesDPCardiovascular disease in the elderlyLibbyPBonowROMannDLZipesDPBraunwald’s Heart Disease: A Textbook of Cardiovascular Medicine2Pennsylvania, PASaunders Elsevier201217271756
   Google Scholar
• AhmedARichMWFlegJLEffects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trialCirculation200611439740316864724
   PubMed Web of Science ®Google Scholar
• FlatherMDShibataMCCoatsAJSENIORS InvestigatorsRandomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)Eur Heart J20052621522515642700
   PubMed Web of Science ®Google Scholar
• FonarowGCStoughWGAbrahamWTOPTIMIZE-HF Investigators HospitalsCharacteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF RegistryJ Am Coll Cardiol20075076877717707182
   PubMed Web of Science ®Google Scholar
• World Health OrganizationDefinition of an older or elderly personGeneva, SwitzerlandWHO2010 Available from: http://www.who.int/healthinfo/survey/ageingdefnolder/en/index.htmlAccessed November 22, 2010
   Google Scholar
• FelkerGMHasselbladVHernandezAFO’ConnorCMBiomarker-guided therapy in chronic heart failure: a meta-analysis or randomized controlled trials associated with a significant reduction in all-cause mortality compared to usual care in patients with chronic heart failureAm Heart J200915842243019699866
   PubMed Web of Science ®Google Scholar
• KarogeropoulosAGeorgeopoulouVPsatyBMInflammatory markers and incident heart failure risk in older adults: the health, aging, and body composition studyJ Am Coll Cardiol201055192129213720447537
   PubMed Web of Science ®Google Scholar
• YusufSPfefferMASwedbergKCHARM Investigators and CommitteesEffects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-preserved trialLancet2003362938677778113678871
   PubMed Web of Science ®Google Scholar
• WinSAnandIMcMurrayJMorbidity and mortality in diabetics with heart failure and a preserved ejection fraction. Result from the I-preserve trialJ Am Coll Cardiol20136110_S1498150623500300
   PubMed Web of Science ®Google Scholar
• LenzenMJScholte op ReimerWJBoersmaEDifferences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure SurveyEur Heart J200425141214122015246639
   PubMed Web of Science ®Google Scholar
• HamdaniNPaulusWJvan HeerebeekLDistinct myocardial effects of beta-blocker therapy in heart failure with normal and reduced left ventricular ejection fractionEur Heart J2009301863187219487234
   PubMed Web of Science ®Google Scholar
• ReilJCHohlMReilGHHeart rate reduction by If-inhibition improves vascular stiffness and left ventricular systolic and diastolic function in a mouse model of heart failure with preserved ejection fractionEur Heart J201334362839294922833515
   PubMed Web of Science ®Google Scholar
• KosmalaWWangMWangTEffect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trialJACC201362151330133823916925
   PubMed Web of Science ®Google Scholar
• DicksteinKCohen-SolalAFilippatosGESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)Eur J Heart Fail20081093398918826876
   PubMed Web of Science ®Google Scholar
• PaulusWJvan BallegoijJJTreatment of heart failure with normal ejection fraction: an inconvenient truthJ Am Coll Cardiol20105552653720152557
   PubMed Web of Science ®Google Scholar
• Van VelhuisenDJLinssenGCJaarmaTB-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fractionJ Am Coll Cardiol201361141498150623500300
   PubMed Web of Science ®Google Scholar
• ClelandJGTenderaMAdamusJPEP-CHF InvestigatorsThe perindopril in elderly people with chronic heart failure (PEP-CHF) studyEur Heart J2006272338234516963472
   PubMed Web of Science ®Google Scholar
• PittBPfefferMAAssmannSFTOPCAT InvestigatorsSpironolactone for heart failure with preserved ejection fraction (TOPCAT)N Engl J Med20143701383139224716680
   PubMed Web of Science ®Google Scholar
• GhioSMagriniGSerioASENIORS InvestigatorsEffects of nebivolol in elderly heart failure patients with or without systolic left ventricular dysfunction: results of the SENIORS echocardiographic substudyEur Heart J20062756256816443607
   PubMed Web of Science ®Google Scholar
• PutkoBNWangZLoJon behalf of the Alberta HEART InvestigatorsCirculating Levels of Tumor Necrosis Factor-Alpha Receptor 2 Are Increased in Heart Failure with Preserved Ejection Fraction Relative to Heart Failure with Reduced Ejection Fraction: Evidence for a Divergence in PathophysiologyPLoS One201496e9949524923671
   PubMed Web of Science ®Google Scholar
• TehraniFPhanAChienCVMorrisseyRPRafiqueAMSchwarzERValue of medical therapy in patients >80 years of age with heart failure and preserved ejection fractionAm J Cardiol200910382983319268740
   PubMed Web of Science ®Google Scholar